申请人:Meiji Seika Kaisha, Ltd.
公开号:EP1184373A1
公开(公告)日:2002-03-06
A compound represented by the formula (I) [A represents a 5- to 7-membered hydrocarbon ring group; L represents -NR3-CO-, -CO-NR3- and the like (R3 represents a hydrogen atom, a lower alkyl group, a lower acyl group and the like); M represents an alkylene linking group (a carbon atom constituting the carbon chain may be replaced with a nitrogen atom, an oxygen atom and the like); X represents -S-, -O-, -NR4-, -NR5-CO- and the like (R4 and R5 represent a hydrogen atom, a lower alkyl group and the like) or a single bond; Y represents an alkyl group, an aryl group, an amino group, an aromatic heterocyclic group and the like; R1 represents a lower alkyl group, a lower alkenyl group, a lower alkynyl group or a lower acyl group; and R21, R22 and R23 represent a hydrogen atom, a hydroxyl group, a lower alkyl group and the like] or a salt thereof. The compound is useful as an active ingredient of medicaments for diseases in which neuropeptide Y is involved, ingestion control for hyperphagia and the like.
由式(I)代表的化合物[A 代表 5 至 7 元烃环基;L 代表-NR3-CO-、-CO-NR3-等(R3 代表氢原子、低级烷基、低级酰基等);M 代表亚烷基连接基团(构成碳链的碳原子可以用氮原子、氧原子等取代);X 代表-S-、-O-、-NR4-、-NR5-CO-等(R4 和 R5 代表氢原子、低级烷基等)或单键;Y 代表烷基、芳基、氨基、芳香杂环基等;R1代表低级烷基、低级烯基、低级炔基或低级酰基;以及 R21、R22 和 R23 代表氢原子、羟基、低级烷基等]或其盐。该化合物可用作治疗涉及神经肽 Y 的疾病的药物的活性成分、控制食欲亢进的药物等。